rt-105
Generic: adalimumab biosimilar·Code: RT-105
rt-105: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | Preclinical |
Get deeper analysis on rt-105
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis